Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 4.977
Filter
1.
Vet Med Sci ; 10(3): e1465, 2024 May.
Article in English | MEDLINE | ID: mdl-38709141

ABSTRACT

A 6-year-old male golden retriever presented with swelling of the left upper eyelid of 2 months duration, which did not improve following a course of antibiotics. Routine serum biochemistry, complete blood count and diagnostic imaging identified no clinically significant abnormalities. The mass was surgically excised, and histopathologic examination was performed. Eosinophilic granulocytic sarcoma (GS) was diagnosed based on the results of histopathology and immunohistochemistry. This is the first report of GS affecting the eyelid of a dog.


Subject(s)
Dog Diseases , Sarcoma, Myeloid , Animals , Dogs , Male , Dog Diseases/surgery , Dog Diseases/diagnosis , Dog Diseases/pathology , Sarcoma, Myeloid/veterinary , Sarcoma, Myeloid/diagnosis , Sarcoma, Myeloid/pathology , Sarcoma, Myeloid/surgery , Eyelid Neoplasms/veterinary , Eyelid Neoplasms/surgery , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathology
3.
Ophthalmologie ; 121(5): 366-373, 2024 May.
Article in German | MEDLINE | ID: mdl-38700760

ABSTRACT

Orbital and periocular metastatic tumors used to be considered very rare; however, with the constant updating of drugs and detection methods for cancer treatment, new chemotherapies and radiation treatments are being used. The life expectancy of cancer patients has become longer and periocular metastases are becoming easier to detect. Our knowledge of this rare disease of metastases also needs to be updated. This article reviews the incidence, symptomatic presentation, clinical features, diagnostic approaches and current treatment of metastatic tumors of the orbit and ocular adnexa in these patients.


Subject(s)
Orbital Neoplasms , Humans , Orbital Neoplasms/secondary , Orbital Neoplasms/therapy , Eyelid Neoplasms/therapy , Eyelid Neoplasms/pathology , Eyelid Neoplasms/epidemiology , Eyelid Neoplasms/secondary , Eye Neoplasms/secondary , Eye Neoplasms/therapy , Eye Neoplasms/pathology
4.
Asia Pac J Ophthalmol (Phila) ; 13(2): 100057, 2024.
Article in English | MEDLINE | ID: mdl-38615904

ABSTRACT

In this review, we aim to provide an overview of the five most common malignant eyelid tumors with current treatment recommendations based on international guidelines. Particular attention is paid to the clinicopathological correlation and the update with regard to adequate treatment. Newer systemic therapies enrich the existing treatment options, of which complete tumor excision remains the most important therapeutic measure.


Subject(s)
Eyelid Neoplasms , Humans , Eyelid Neoplasms/therapy , Eyelid Neoplasms/pathology
5.
Turk J Ophthalmol ; 54(2): 116-119, 2024 Apr 19.
Article in English | MEDLINE | ID: mdl-38646410

ABSTRACT

Merkel cell carcinoma (MCC) is an unusual skin tumor that has a significant rate of distant and local metastases. It is known that primary MCC of the eyelid usually occurs at the upper eyelid. Here we report an unusual case of MCC metastasis to the eyelid. A 63-year-old male was diagnosed with MCC three years earlier after initially presenting with a mass in his right thigh. After histopathological diagnosis, the patient received medical therapy. During treatment, he developed multiple distant metastases and a firm, purple, vascularized lesion on the upper eyelid. We confirmed the lesion was an eyelid metastasis of MCC by histopathological examination and imaging methods. This case shows that extraocular MCC can metastasize to the eyelids, particularly the upper eyelid, where primary periocular MCC usually appears.


Subject(s)
Carcinoma, Merkel Cell , Eyelid Neoplasms , Skin Neoplasms , Humans , Male , Carcinoma, Merkel Cell/secondary , Carcinoma, Merkel Cell/diagnosis , Middle Aged , Eyelid Neoplasms/secondary , Eyelid Neoplasms/diagnosis , Skin Neoplasms/secondary , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology , Biopsy , Eyelids/pathology
6.
Curr Oncol ; 31(4): 1713-1724, 2024 03 22.
Article in English | MEDLINE | ID: mdl-38668033

ABSTRACT

INTRODUCTION: The eyelids are a common site for skin tumours and account for 5-10% of all skin tumours. Treatment is mainly surgical and aims to preserve the anatomical structure of the eyelid, its function and not least its aesthetic appearance. AIM: Presentation of recurrence and complication rates of tumour-related eyelid surgery in a cohort of 450 tumours. RESULTS: Analysis of a cohort of 450 tumours operated on revealed 13 (2.8%) operations with recurrences and 32 (7%) with complications. The statistical significance of recurrences was observed for the involved and uninvolved ciliary margin. At the temporal canthus, 23.1% of recurrences occurred compared to 7.7% at the medial canthus. SGC has the highest recurrence rate. Complications include the following: ectropion, dehiscence, gross cicatrix with normal function, retraction, post-radiation damage, sub-graft haemorrhage and graft rejection. CONCLUSIONS: The recurrence rate of eyelid tumours is lower than that of complications. The choice of surgical technique determines the frequency of complications and histological control of the excised tissue, as well as the frequency of recurrences.


Subject(s)
Eyelid Neoplasms , Neoplasm Recurrence, Local , Plastic Surgery Procedures , Humans , Eyelid Neoplasms/surgery , Female , Male , Plastic Surgery Procedures/methods , Middle Aged , Aged , Postoperative Complications/etiology , Adult , Aged, 80 and over , Eyelids/surgery
8.
Arch Dermatol Res ; 316(4): 106, 2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38489027

ABSTRACT

No randomized trials exist to inform the peripheral surgical margins or depth of wide excision for eyelid melanoma. We performed a meta-analysis examining surgical margins and Breslow depth for eyelid melanomas. A systematic review was performed in August 2022 using PubMed, Cochrane, and Medline databases (1/1/1990 to 8/1/2022). Inclusion criteria included studies reporting surgical treatment of primary cutaneous melanomas of the eyelid with reported surgical margins. Ten articles were included. The studies were examined by surgical margin size (group 1: ≤ 0.5 cm; group 2 > 0.5 cm and ≤ 1.5 cm) and Breslow depth (group 1: ≤ 1 mm; group 2: > 1 mm). The odds ratio (OR) for local recurrence was 2.55 [95% CI 0.36-18.12], p = 0.18; regional metastasis was 0.70 [95% CI 0.00-23671.71], p = 0.48; and distant metastasis was 2.47 [95% CI 0.00-1687.43], p = 0.66. When examining by Breslow depth, the OR for local recurrence was 0.53 [95% CI 0.14-1.94], p = 0.34; regional metastasis was 0.14 [0.00-176.12], p = 0.54; and the OR for distant metastasis was 0.24 [95% CI 0.01-8.73], p = 0.46. There was a trend toward higher likelihood of recurrence and metastasis in the ≤ 0.5 cm group. Similarly, there is a trend toward higher likelihood of recurrence and metastasis with Breslow depth > 1 mm. A surgical margin of at least 0.5 cm and achievement of negative margins via permanent sections or MMS are likely needed to prevent adverse outcomes. En face sectioning may be a superior method of histological processing for eyelid melanoma.


Subject(s)
Eyelid Neoplasms , Melanoma , Skin Neoplasms , Humans , Melanoma/pathology , Margins of Excision , Skin Neoplasms/surgery , Skin Neoplasms/pathology , Eyelid Neoplasms/surgery , Eyelid Neoplasms/pathology , Eyelids/surgery , Eyelids/pathology , Neoplasm Recurrence, Local/epidemiology , Neoplasm Recurrence, Local/surgery , Neoplasm Recurrence, Local/prevention & control , Retrospective Studies
9.
Ann Plast Surg ; 92(4): e19-e28, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38319960

ABSTRACT

BACKGROUND: Reconstructing full-thickness defects involving 50% to 75% of the horizontal length of the lower eyelid after medial and central full-thickness block resection can be challenging. As a disadvanatge, 1-stage reconstructions may require a free graft reconstruction of the posterior lamella. In addition, 2-stage reconstructions are associated with several complications, including erythema, and the eye must be temporarily closed after surgery. METHODS: The present study describes a single-surgeon retrospective case series. Five patients diagnosed with basal cell carcinoma underwent wide full-thickness block resection with optimal excision margins (3-5 mm). Subsequently, 1-stage reconstruction was performed using the modified Mustardé flap, incised using the transconjunctival approach. This flap comprised the skin, muscle, tarsus, and conjunctival flap raised from the lateral canthus through a lateral cantholysis procedure, and then extended to the lateral cheek. The flap was medially transposed to cover the medial and central lower eyelid defect. The superolateral periosteal flap was harvested from the superolateral orbital rim attached to the lateral border of the tarsus of the modified Mustardé flap. The lateral forniceal conjunctiva was released from the retractor and advanced superiorly to cover the inner surface. RESULTS: The study included 3 men and 2 women, with a mean age of 71 years (range, 62-90 years). Histological evaluations confirmed tumor-free margins in all cases. The average follow-up duration was 20 months (6-60 months), with no tumor recurrence. None of the patients developed long-term complications, such as ectropion, entropion, lagophthalmos, trichiasis, symblepharon, erythema, wound dehiscence, or flap necrosis. All patients had minimal scarring, and no secondary surgical interventions were necessary. CONCLUSIONS: This case series demonstrates the efficacy of the combined modified Mustardé and superolateral periosteal flaps in 1-stage reconstruction of full-thickness defects involving 50% to 75% of the horizontal length of the medial and central lower eyelid without compromising functional and aesthetic outcomes.


Subject(s)
Ectropion , Eyelid Neoplasms , Skin Neoplasms , Male , Humans , Female , Aged , Retrospective Studies , Neoplasm Recurrence, Local , Eyelids/surgery , Postoperative Complications , Erythema , Eyelid Neoplasms/surgery
10.
JAMA Ophthalmol ; 142(3): 266-267, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38329738

ABSTRACT

A 62-year-old male was referred for evaluation of a painless right lower-eyelid lesion noted during routine glaucoma follow-up. The lesion had been present for 3 years with slow, gradual enlargement. What would you do next?


Subject(s)
Eyelid Neoplasms , Male , Humans , Middle Aged , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/surgery , Eyelid Neoplasms/pathology , Eyelids/pathology
12.
J Craniofac Surg ; 35(4): e325-e329, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38385685

ABSTRACT

PURPOSE: To describe a modified approach for full-thickness lower eyelid defect reconstruction. METHODS: This is a retrospective review of 5 patients with large full-thickness lower eyelid defects after tumor resection requiring reconstruction. For these lower eyelid defects, a lateral-based or superior-based tarsoconjunctival pedicle flap from the upper eyelid was used to rebuild the posterior lamella. In all cases, the anterior lamella was supplied from an adjacent myocutaneous flap in a bucket handle configuration. Data collection included tumor type and location, size of eyelid defect, presence of canalicular involvement, postoperative eyelid position, patient satisfaction, and complication rates. RESULTS: Five eyelids of 5 patients underwent Mohs micrographic excision of basal cell carcinoma followed by reconstruction with a bucket handle flap. Age range was 68 to 96 years old (mean of 81 y). Five patients presented with lower eyelid involvement. The defect size ranged from 80% to 100% of the eyelid. Three patients had canalicular involvement and required bicanalicular nasolacrimal stent placement. After reconstruction, all patients showed good eyelid apposition to the globe with excellent esthetic outcome. No revision procedures were done. Average follow-up time was 13 months (range of 8 to 21 mo). CONCLUSION: The bucket handle flap for full-thickness eyelid reconstruction is a simple technique that allows for preservation of all anatomical layers of the anterior lamella. This technique shows promising functional and esthetic outcomes.


Subject(s)
Carcinoma, Basal Cell , Eyelid Neoplasms , Mohs Surgery , Surgical Flaps , Humans , Aged , Eyelid Neoplasms/surgery , Aged, 80 and over , Retrospective Studies , Male , Female , Carcinoma, Basal Cell/surgery , Treatment Outcome , Plastic Surgery Procedures/methods , Blepharoplasty/methods , Eyelids/surgery , Patient Satisfaction
13.
Int J Dermatol ; 63(6): 726-736, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38351466

ABSTRACT

Periocular sebaceous carcinoma (PSC) is a rare, aggressive, and potentially metastatic adnexal malignancy. Due to the ability of PSC to resemble several benign and malignant conditions, diagnosis is often delayed or mistaken. In addition, even with a known diagnosis, choosing the right treatment is still an open debate. For this reason, we decided to review the most up-to-date literature on PSC and propose a dedicated procedural protocol to help clinicians when dealing with PSC. A PubMed search was carried out using the terms "Sebaceous Carcinoma", "Adnexal Periocular Cancer", "Sebaceous Carcinoma AND eyelid", "Periocular Sebaceous Carcinoma", and "Ocular Adnexa". Pertinent studies published in English from 1997 up to December 2022 were compared to the selection criteria and if suitable, included in this review. Through the initial search, 84 articles were selected. Of these, 36 were included in the final study. Several papers explored different diagnostic and therapeutic strategies regarding PSC diagnosis and management. In light of the current literature review and the multidisciplinary experience of three clinical centers, a dedicated procedural protocol is proposed. PSC diagnosis may be achieved through accurate clinical evaluation, but it requires histopathologic confirmation, which can be challenging. Dermoscopy, in vivo reflectance confocal microscopy, and optical coherence tomography may facilitate PSC clinical examination, while immunohistochemistry stains may support histological diagnosis. Appropriate disease staging is necessary before choosing the treatment, as local disease requires radically different treatment compared to advanced disease. In addition, recent innovations in nonsurgical treatments, including radio-chemotherapy, immunotherapy, and targeted therapy, may be a viable option in the most challenging cases.


Subject(s)
Adenocarcinoma, Sebaceous , Eyelid Neoplasms , Neoplasm Staging , Sebaceous Gland Neoplasms , Humans , Sebaceous Gland Neoplasms/therapy , Sebaceous Gland Neoplasms/diagnosis , Sebaceous Gland Neoplasms/pathology , Eyelid Neoplasms/therapy , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathology , Adenocarcinoma, Sebaceous/therapy , Adenocarcinoma, Sebaceous/diagnosis , Adenocarcinoma, Sebaceous/pathology , Dermoscopy , Diagnosis, Differential
14.
Eye (Lond) ; 38(8): 1496-1501, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38388832

ABSTRACT

PURPOSE: Orbital surgery benefits from well-designed instrumentation that offers gentle tissue manipulation, high manoeuvrability and control. Nevertheless, in confined spaces, tissue manipulation must be accomplished with exceptionally high accuracy and precision. This is where robotic surgery offers an advantage. We aimed to evaluate a robotic-assisted surgical system's feasibility, safety and outcome in assisting tumour clearance. PATIENTS AND METHODS: A case series of patients with advanced periocular tumours undergoing robotic-assisted globe-sparing resection was performed using the DaVinci XI system (Intuitive Surgical, Inc). Institutional ethics and multidisciplinary approval were sought in all cases. RESULTS: Four patients with advanced periocular tumours underwent robotic-assisted orbital surgery at a mean age of 63 years (range 42-86). Two patients were diagnosed with squamous cell carcinoma, and two had basal cell carcinoma. One patient was found to have positive lymph nodes at the time of surgery and underwent simultaneous parotidectomy and lymph node clearance. Clear resection of the primary tumour was achieved in all patients; three patients underwent further resection due to narrow margins prior to reconstruction. Patients were follow-up for at least one year, and three remained disease-free. One patient with pre-existing extra-orbital disease developed metastatic disease four months post-op. All patients preserved vision peri-operatively, with no complaints of diplopia. Moderate ocular surface disease was noted in two patients. CONCLUSION: Our series highlights the potential advantage of three-dimensional optics, multi-directional instrumentation and motion scaling technology to achieve globe-sparing tumour resection in advanced periocular tumours. However, further robotic instrumentation development is required for orbital surgery.


Subject(s)
Carcinoma, Squamous Cell , Feasibility Studies , Orbital Neoplasms , Robotic Surgical Procedures , Humans , Middle Aged , Male , Robotic Surgical Procedures/methods , Female , Aged , Adult , Aged, 80 and over , Carcinoma, Squamous Cell/surgery , Carcinoma, Squamous Cell/pathology , Orbital Neoplasms/surgery , Carcinoma, Basal Cell/surgery , Ophthalmologic Surgical Procedures/methods , Treatment Outcome , Orbit/surgery , Eyelid Neoplasms/surgery
15.
Indian J Pathol Microbiol ; 67(2): 456-458, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38391357

ABSTRACT

ABSTRACT: Skin adnexal or sweat gland neoplasms are rare adnexal tumors that pose a diagnostic challenge for both ophthalmologists and pathologists. Endocrine mucin-producing sweat gland carcinoma (EMPSGC) is an uncommon low grade carcinoma of eccrine ducts with a predilection to occur in the periocular region in the elderly female. We present a rare case of 65-year-old healthy male who presented with a lobulated mass in the left eye lower lid, clinically suspected as sebaceous gland carcinoma, diagnosed as endocrine mucin-producing sweat gland carcinoma histopathologically.


Subject(s)
Eyelid Neoplasms , Mucins , Sweat Gland Neoplasms , Humans , Male , Aged , Sweat Gland Neoplasms/diagnosis , Sweat Gland Neoplasms/pathology , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/pathology , Eyelids/pathology , Diagnosis, Differential , Carcinoma/diagnosis , Carcinoma/pathology , Immunohistochemistry
16.
Biomed Eng Online ; 23(1): 25, 2024 Feb 28.
Article in English | MEDLINE | ID: mdl-38419078

ABSTRACT

BACKGROUND: The accurate detection of eyelid tumors is essential for effective treatment, but it can be challenging due to small and unevenly distributed lesions surrounded by irrelevant noise. Moreover, early symptoms of eyelid tumors are atypical, and some categories of eyelid tumors exhibit similar color and texture features, making it difficult to distinguish between benign and malignant eyelid tumors, particularly for ophthalmologists with limited clinical experience. METHODS: We propose a hybrid model, HM_ADET, for automatic detection of eyelid tumors, including YOLOv7_CNFG to locate eyelid tumors and vision transformer (ViT) to classify benign and malignant eyelid tumors. First, the ConvNeXt module with an inverted bottleneck layer in the backbone of YOLOv7_CNFG is employed to prevent information loss of small eyelid tumors. Then, the flexible rectified linear unit (FReLU) is applied to capture multi-scale features such as texture, edge, and shape, thereby improving the localization accuracy of eyelid tumors. In addition, considering the geometric center and area difference between the predicted box (PB) and the ground truth box (GT), the GIoU_loss was utilized to handle cases of eyelid tumors with varying shapes and irregular boundaries. Finally, the multi-head attention (MHA) module is applied in ViT to extract discriminative features of eyelid tumors for benign and malignant classification. RESULTS: Experimental results demonstrate that the HM_ADET model achieves excellent performance in the detection of eyelid tumors. In specific, YOLOv7_CNFG outperforms YOLOv7, with AP increasing from 0.763 to 0.893 on the internal test set and from 0.647 to 0.765 on the external test set. ViT achieves AUCs of 0.945 (95% CI 0.894-0.981) and 0.915 (95% CI 0.860-0.955) for the classification of benign and malignant tumors on the internal and external test sets, respectively. CONCLUSIONS: Our study provides a promising strategy for the automatic diagnosis of eyelid tumors, which could potentially improve patient outcomes and reduce healthcare costs.


Subject(s)
Eyelid Neoplasms , Humans , Eyelid Neoplasms/diagnosis , Area Under Curve , Health Care Costs
18.
Ir J Med Sci ; 193(3): 1209-1213, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38289579

ABSTRACT

PURPOSE: To report the margin control process and rate of recurrence of periocular basal cell carcinomas (BCCs) managed by en-face, frozen section margin controlled (FSC), excision by a single surgeon with a 3-year follow-up. METHODS: A retrospective analysis of all histopathologically proven cases of periocular BCC who underwent surgical excision with intra-operative, en-face, FSC, excision by a single surgeon from 2015 to 2019 was performed. Patients with less than 3-year follow-up were offered a virtual appointment to determine possible recurrence. RESULTS: A total of 88 BCC excisions from 86 patients were reviewed. Minimum 3-year follow-up data is available for 73 patients. The most common location and histological subtype was the lower eyelid and nodular BCC, respectively (47% and 83% of cases). Primary BCC (pBCC) comprised 98% (86/88) of cases and recurrent BCC (rBCC) comprised 2% (2/88) of cases. Negative frozen section margins were achieved in 93% (82/88) of excisions on the day of surgery. The overall recurrence rate during this time was 1.4% (1/73) at minimum 3 years. CONCLUSION: Periocular BCC can be managed effectively by en-face, FSC, excision, with a high cure rate and low recurrence rate comparable to alternative excision techniques such as Moh's micrographic surgery. Advantages of en-face excision include same-day excision and reconstruction and reduced theatre time. Primary nodular BCCs with clear margins can be considered for early discharge with advice to self-monitor.


Subject(s)
Carcinoma, Basal Cell , Frozen Sections , Margins of Excision , Neoplasm Recurrence, Local , Skin Neoplasms , Humans , Carcinoma, Basal Cell/surgery , Carcinoma, Basal Cell/pathology , Female , Male , Retrospective Studies , Aged , Middle Aged , Frozen Sections/statistics & numerical data , Skin Neoplasms/surgery , Skin Neoplasms/pathology , Aged, 80 and over , Eyelid Neoplasms/surgery , Eyelid Neoplasms/pathology , Adult
19.
BMC Ophthalmol ; 24(1): 1, 2024 Jan 02.
Article in English | MEDLINE | ID: mdl-38166705

ABSTRACT

BACKGROUND: Angiosarcoma is an extremely rare malignant tumor. So far, only about 42 cases of angiosarcoma involving the eyelids have been reported. Eyelid angiosarcoma occurs more frequently in elderly Caucasian males and is prone to misdiagnosis. We present a case report in a young Asian male patient with eyelid angiosarcoma that was misdiagnosed as a chalazion. CASE PRESENTATION: A 46-year-old South Korean male with no underlying disease had a right lower lid mass. The lesion was initially misdiagnosed as a chalazion at a local clinic, but a diagnosis of eyelid angiosarcoma was made after the first biopsy trial. PET-CT was performed to ensure that there was no metastasis in the whole body. Surgical excision with enough surgical margin was used alone for treatment and reconstruction was performed with a tarsoconjunctival advancement flap (modified Hughes procedure), which helped ensure good cosmesis. No recurrence was observed 4 years and 5 months after the surgery. CONCLUSIONS: The current study presents the first case of chalazion-mimicked eyelid angiosarcoma in a young Asian male aged under 50 years. This case shows that even if a benign eyelid disease is suspected in a young patient, an incisional biopsy must be performed to confirm whether the lesion is malignant. Since the prognosis is good for the case of eyelid angiosarcoma, if there is no clear evidence of distal metastasis, surgical resection should be performed with an enough safety margin.


Subject(s)
Chalazion , Eyelid Neoplasms , Hemangiosarcoma , Aged , Male , Humans , Middle Aged , Chalazion/diagnosis , Eyelid Neoplasms/diagnosis , Eyelid Neoplasms/surgery , Eyelid Neoplasms/pathology , Hemangiosarcoma/diagnosis , Hemangiosarcoma/surgery , Hemangiosarcoma/pathology , Positron Emission Tomography Computed Tomography , Eyelids/surgery , Eyelids/pathology
20.
JAMA Ophthalmol ; 142(1): e234717, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-38236265

ABSTRACT

This case report describes a diagnosis of pigmented squamous cell carcinoma in situ in a female patient aged 61 years who presented with a pigmented lesion on her medial canthus that had been growing over a 2-year period.


Subject(s)
Carcinoma, Squamous Cell , Eyelid Neoplasms , Humans , Eyelids/pathology , Carcinoma, Squamous Cell/diagnosis , Eyelid Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...